NCT02808273View on ClinicalTrials.gov

Use of Bemiparine as a Prophylactic Antithrombotic Agent, in Patients Undergoing Microsurgery for Head and Neck Reconstruction

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 2, 2016

Primary Completion Date

October 12, 2018

Study Completion Date

October 12, 2018

Conditions

Patients Undergoing Microvascular Surgery

Interventions

DRUG

Bemiparine

Bemiparine 3500 UI as antithrombotic according to a protocol for prevention of postoperative deep venous thrombosis

Trial Locations (1)

28034

Ramon y Cajal Hospital, Madrid

All Listed Sponsors

collaborator

Rovi Pharmaceuticals Laboratories

INDUSTRY

lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER

NCT02808273 - Use of Bemiparine as a Prophylactic Antithrombotic Agent, in Patients Undergoing Microsurgery for Head and Neck Reconstruction | Biotech Hunter | Biotech Hunter